Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Hepatitis A Virus (HAV) Antibody Persistence in Children Vaccinated With 1 Dose and Those Vaccinated With 2 Doses of Havrix in Panama

NCT02712359 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02712359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02712359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Hepatitis A Virus (HAV) Antibody Persistence in Children Vaccinated With 1 Dose and Those Vaccinated With 2 Doses of Havrix in Panama
Lead sponsor
GlaxoSmithKline
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2016
Completion date
August 22, 2018
Enrollment
1,201 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis a vaccine